GIANT BIOGENE(02367)
Search documents
巨子生物12月15日耗资约1391.73万港元回购40万股
Zhi Tong Cai Jing· 2025-12-15 12:36
巨子生物(02367)公布,2025年12月15日耗资约1391.73万港元回购40万股股份。 ...
巨子生物(02367)12月15日耗资约1391.73万港元回购40万股
智通财经网· 2025-12-15 12:32
智通财经APP讯,巨子生物(02367)公布,2025年12月15日耗资约1391.73万港元回购40万股股份。 ...
巨子生物(02367) - 翌日披露报表
2025-12-15 12:26
呈交日期: 2025年12月15日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02367 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | 庫存股份變動 | | | | | 事件 | 已發行股份(不包括庫存股份)數 目 | 佔有關事件前的現有已發 行股份(不包括庫存股 份)數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | 於下列日期開始時的結存(註1) | 2025年12月12日 | 1 ...
智通港股回购统计|12月15日





智通财经网· 2025-12-15 01:25
Summary of Key Points Core Viewpoint - The article discusses the stock buyback activities of various companies, highlighting the amounts repurchased and their significance in terms of total shares outstanding. Group 1: Major Buybacks - Tencent Holdings (00700) had the largest buyback, repurchasing 1.044 million shares for a total of 636 million [1][2] - China Merchants Industry Holdings (01919) repurchased 4.461 million shares for 60.86 million, representing 2.986% of its total shares [2] - Geely Automobile (00175) bought back 1.362 million shares for 23.92 million, which is 0.078% of its total shares [2] Group 2: Notable Buyback Activities - China Feihe (06186) repurchased 5.655 million shares for 23.18 million, accounting for 2.605% of its total shares [2] - Yum China (09987) conducted two buybacks totaling 58,000 shares for 21.67 million, representing 4.750% of its total shares [2] - Kweichow Moutai (01951) repurchased 772,200 shares for 19.35 million, which is 0.280% of its total shares [2] Group 3: Other Companies Involved - Vitasoy International (00345) repurchased 2,000 shares for 13,300, which is 2.209% of its total shares [3] - Yanzhiyu (01497) bought back 200,000 shares for 1.39 million, representing 0.786% of its total shares [3] - Weigao Group (01066) repurchased 120,000 shares for 631,000, which is 5.179% of its total shares [3]
巨子生物(02367.HK)12月12日回购1403.64万港元,已连续4日回购
Zheng Quan Shi Bao Wang· 2025-12-12 15:52
Group 1 - The core point of the article is that Giant Bio (02367.HK) has been actively repurchasing its shares, with a total repurchase amount of HKD 5,668.27 million over four consecutive days [1] - On December 12, the company repurchased 400,000 shares at prices ranging from HKD 35.000 to HKD 35.220, totaling HKD 1,403.64 million [1] - The stock price on the same day closed at HKD 35.100, reflecting a 2.15% increase, while the stock had a cumulative decline of 3.57% during the repurchase period [1] Group 2 - The repurchase details include the number of shares repurchased, the highest and lowest prices, and the total repurchase amount for each day from December 9 to December 12 [1] - The daily repurchase data shows consistent activity, with 40,000 shares repurchased each day over the four days [1] - The highest repurchase price during this period was HKD 36.220 on December 10, while the lowest was HKD 34.200 on December 11 [1]
巨子生物(02367.HK)12月12日耗资1403.6万港元回购40万股
Ge Long Hui· 2025-12-12 11:05
Group 1 - The company, Giant Bio (02367.HK), announced a share buyback on December 12, spending HKD 14.036 million to repurchase 400,000 shares [1]
巨子生物(02367)12月12日耗资约1403.64万港元回购40万股
智通财经网· 2025-12-12 11:02
Group 1 - The company, Giant Bio (02367), announced a share buyback plan, intending to repurchase 400,000 shares at a cost of approximately HKD 14.0364 million [1]
巨子生物(02367) - 翌日披露报表
2025-12-12 10:57
FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 公司名稱: 巨子生物控股有限公司 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02367 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | 庫存股份變動 | | | | | 事件 | 已發行股份(不包括庫存股份)數 目 | 佔有關事件前的現有已發 行股份(不包括庫存股 份)數目百分比 (註3) | 庫存股份數目 | 每股發行/出售價 (註4) | 已發行股份總數 | | 於下列日期開始時的結存(註1) | 2025年12月11日 | 1,070,904,000 | | 0 | | 1,070,904,000 | | 1). 其他 (請註明) | | | % | | ...
新消费概念股普涨 茶百道(02555)涨5.76% 机构料明年促消费政策持续发力有望激发供需潜力
Xin Lang Cai Jing· 2025-12-12 04:16
Core Viewpoint - New consumption concept stocks are experiencing a broad increase, indicating a positive market sentiment and potential growth in the sector [1][2] Stock Performance - Notable stock increases include: - Cha Bai Dao (02555) up by 5.76% - Guo Quan (02517) up by 4.50% - Lao Pu Gold (06181) up by 4.14% - Miniso (09896) up by 3.00% - Hu Shang A Yi (02589) up by 2.84% - Juzi Biotechnology (02367) up by 2.97% [1][2] Industry Outlook - According to Huatai Securities, the differentiation between new and old consumption will continue into 2025, driven by changes in "people, goods, and venues" and technological advancements [1][2] - The report anticipates that consumer policies will stimulate supply and demand potential, leading to a steady recovery in domestic demand and continued industry differentiation in 2026 [1][2] Investment Focus - The report suggests focusing on four main investment themes: 1. Rise of domestic brands: Attention on潮玩 (trendy toys), beauty and personal care, and gold jewelry brands competing in both domestic and international markets [1][2] 2. Technology-enabled consumption: Emphasis on the rapid increase in smart product penetration rates due to technological and product innovation [1][2] 3. Emotional consumption: Monitoring growth potential in service consumption, ready-to-drink beverages, pets, and new tobacco products [1][2] 4. Undervalued high-dividend blue-chip leaders: Focus on opportunities for marginal recovery while balancing risk and reward [1][2]
巨子生物(02367.HK)连续3日回购,累计斥资4264.64万港元
Zheng Quan Shi Bao Wang· 2025-12-11 13:48
Group 1 - The core point of the article is that Juzhi Biotechnology has been actively repurchasing its shares on the Hong Kong Stock Exchange, indicating a strategy to support its stock price amid recent declines [2] - On December 11, the company repurchased 400,000 shares at a price range of HKD 34.200 to HKD 35.360, totaling HKD 13.8876 million [2] - The stock closed at HKD 34.360 on the same day, reflecting a decline of 5.08%, with a total trading volume of HKD 563 million [2] Group 2 - Since December 9, the company has conducted share repurchases for three consecutive days, accumulating a total of 1.2 million shares repurchased and a total expenditure of HKD 42.6464 million [2] - During this period, the stock has experienced a cumulative decline of 5.60% [2] - The detailed repurchase information includes the number of shares, highest and lowest repurchase prices, and total repurchase amounts for each day [2]